IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm

NCT00406367 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharospasm

Interventions

DRUG: incobotulinumtoxinA (Xeomin)
DRUG: Placebo

Sponsor

Merz Pharmaceuticals GmbH